- Home
- MGM vs ASND Comparison
MGM vs ASND Comparison
Compare MGM & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGM
- ASND
- Stock Information
- Founded
- MGM 1986
- ASND 2006
- Country
- MGM United States
- ASND Denmark
- Employees
- MGM N/A
- ASND N/A
- Industry
- MGM Hotels/Resorts
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- MGM Consumer Discretionary
- ASND Health Care
- Exchange
- MGM Nasdaq
- ASND Nasdaq
- Market Cap
- MGM 9.2B
- ASND 10.6B
- IPO Year
- MGM N/A
- ASND 2015
- Fundamental
- Price
- MGM $37.36
- ASND $168.53
- Analyst Decision
- MGM Buy
- ASND Strong Buy
- Analyst Count
- MGM 16
- ASND 17
- Target Price
- MGM $47.21
- ASND $222.18
- AVG Volume (30 Days)
- MGM 4.1M
- ASND 419.9K
- Earning Date
- MGM 07-30-2025
- ASND 09-02-2025
- Dividend Yield
- MGM N/A
- ASND N/A
- EPS Growth
- MGM N/A
- ASND N/A
- EPS
- MGM 2.24
- ASND N/A
- Revenue
- MGM $17,134,157,000.00
- ASND $398,509,511.00
- Revenue This Year
- MGM $0.62
- ASND $77.19
- Revenue Next Year
- MGM $1.63
- ASND $75.84
- P/E Ratio
- MGM $16.69
- ASND N/A
- Revenue Growth
- MGM 2.69
- ASND 12.06
- 52 Week Low
- MGM $25.30
- ASND $111.09
- 52 Week High
- MGM $43.99
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- MGM 56.75
- ASND 48.47
- Support Level
- MGM $36.70
- ASND $165.24
- Resistance Level
- MGM $38.87
- ASND $179.96
- Average True Range (ATR)
- MGM 0.88
- ASND 6.03
- MACD
- MGM -0.14
- ASND -0.90
- Stochastic Oscillator
- MGM 41.25
- ASND 37.30
About MGM MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 37,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Park MGM, Luxor, New York-New York, and Bellagio. The Strip contributed approximately 59% of total EBITDAR in 2024. MGM also owns US regional assets, which represented a low 20s share of 2024 EBITDAR (MGM's Macao EBITDAR was 21% of the total in 2024). MGM's US sports and i-gaming operations are currently a high-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM China casinos with a new property that opened on the Cotai Strip in early 2018. We estimate MGM will open a resort in Japan in 2030.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.